Display options
Cite
Gandhi S, McArthur E, Reiss JP, et al. Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Can J Kidney Health Dis. 2016;3:21doi: 10.1186/s40697-016-0111-z.
Gandhi, S., McArthur, E., Reiss, J. P., Mamdani, M. M., Hackam, D. G., Weir, M. A., & Garg, A. X. (2016). Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Canadian journal of kidney health and disease, 321. https://doi.org/10.1186/s40697-016-0111-z
Gandhi, Sonja, et al. "Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study." Canadian journal of kidney health and disease vol. 3 (2016): 21. doi: https://doi.org/10.1186/s40697-016-0111-z
Gandhi S, McArthur E, Reiss JP, Mamdani MM, Hackam DG, Weir MA, Garg AX. Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study. Can J Kidney Health Dis. 2016 Apr 11;3:21. doi: 10.1186/s40697-016-0111-z. eCollection 2016. PMID: 27069639; PMCID: PMC4827184.
Copy Download .nbib Format: NLM
Share it on

Can J Kidney Health Dis. 2016 Apr 11;3:21. doi: 10.1186/s40697-016-0111-z. eCollection 2016.

Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study.

Canadian journal of kidney health and disease

Sonja Gandhi, Eric McArthur, Jeffrey P Reiss, Muhammad M Mamdani, Daniel G Hackam, Matthew A Weir, Amit X Garg

Affiliations

  1. Department of Epidemiology and Biostatistics, Western University, London, Ontario Canada ; Division of Nephrology, Department of Medicine, Western University, London, Ontario Canada.
  2. Division of Nephrology, Department of Medicine, Western University, London, Ontario Canada ; Institute for Clinical Evaluative Sciences, Toronto, Ontario Canada.
  3. Department of Psychiatry, Western University, London, Ontario Canada.
  4. Institute for Clinical Evaluative Sciences, Toronto, Ontario Canada ; Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario Canada.
  5. Institute for Clinical Evaluative Sciences, Toronto, Ontario Canada ; Division of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario Canada.
  6. Department of Epidemiology and Biostatistics, Western University, London, Ontario Canada ; Division of Nephrology, Department of Medicine, Western University, London, Ontario Canada ; Institute for Clinical Evaluative Sciences, Toronto, Ontario Canada ; Institute for Clinical Evaluative Sciences, Room ELL-101, Westminster, London Health Sciences Centre, 800 Commissioners Road East, London, Ontario N6A 4G5 Canada.

PMID: 27069639 PMCID: PMC4827184 DOI: 10.1186/s40697-016-0111-z

Abstract

BACKGROUND: A number of case reports have suggested a possible association between atypical antipsychotic medications and hyponatremia. Currently, there are no reliable estimates of hyponatremia risk from atypical antipsychotic drugs.

OBJECTIVE: The objective of this study was to examine the 30-day risk of hospitalization with hyponatremia in older adults dispensed an atypical antipsychotic drug relative to no antipsychotic use.

DESIGN: The design of this study was a retrospective, population-based cohort study.

SETTING: The setting of this study was in Ontario, Canada, from 2003 to 2012.

PATIENTS: Adults 65 years or older with an identified psychiatric condition who were newly dispensed risperidone, olanzapine, or quetiapine in the community setting compared to adults with similar indicators of baseline health who were not dispensed such a prescription.

MEASUREMENTS: The primary outcome was the 30-day risk of hospitalization with hyponatremia. The tracer outcome (an outcome that is not expected to be influenced by the study drugs) was the 30-day risk of hospitalization with bowel obstruction. These outcomes were assessed using hospital diagnosis codes.

METHODS: Using health administrative data, we applied a propensity score technique to match antipsychotic users 1:1 to non-users of antipsychotic drugs (58,008 patients in each group). We used conditional logistic regression to compare outcomes among the matched users and non-users.

RESULTS: A total of 104 baseline characteristics were well-balanced between the two matched groups. Atypical antipsychotic use compared to non-use was associated with an increased risk of hospitalization with hyponatremia within 30 days (86/58,008 (0.15 %) versus 53/58,008 (0.09 %); relative risk 1.62 (95 % confidence interval (CI) 1.15 to 2.29); absolute risk increase 0.06 % (95 % CI 0.02 to 0.10)). The limited number of events precluded some additional analyses to confirm if the association was robust. Atypical antipsychotic use compared to non-use was not associated with hospitalization with bowel obstruction within 30 days (55/58,008 (0.09 %) versus 44/58,008 (0.08 %); relative risk 1.25 (95 % CI 0.84 to 1.86)).

LIMITATIONS: We could only study older adults within our data sources.

CONCLUSIONS: In this study, the use of an atypical antipsychotic was associated with a modest but statistically significant increase in the 30-day risk of a hospitalization with hyponatremia. The association was less pronounced than that described with other psychotropic drugs.

Keywords: Atypical antipsychotic; Hyponatremia; Low serum sodium; Olanzapine; Psychotropic; Quetiapine; Risperidone

References

  1. QJM. 2008 Jul;101(7):583-8 - PubMed
  2. Stat Med. 2002 Jul 30;21(14):2027-44 - PubMed
  3. Ann Intern Med. 2013 Jun 18;158(12):869-76 - PubMed
  4. Drug Saf. 2010 Jul 1;33(7):569-78 - PubMed
  5. South Med J. 2007 Aug;100(8):832-3 - PubMed
  6. Am J Gastroenterol. 2014 May;109 (5):686-94 - PubMed
  7. JAMA. 2011 Sep 28;306(12):1359-69 - PubMed
  8. Clin J Am Soc Nephrol. 2010 Sep;5(9):1544-51 - PubMed
  9. J Clin Psychopharmacol. 2009 Apr;29(2):186-9 - PubMed
  10. BMJ Open. 2012 Dec 28;2(6):null - PubMed
  11. Am J Med. 2006 Jan;119(1):71.e1-8 - PubMed
  12. JAMA. 2013 Dec 18;310(23):2544-53 - PubMed
  13. Can J Clin Pharmacol. 2003 Summer;10(2):67-71 - PubMed
  14. BMC Nephrol. 2013 Apr 05;14:81 - PubMed
  15. Schizophr Bull. 2004;30(2):255-64 - PubMed
  16. Int J Geriatr Psychiatry. 2005 Aug;20(8):749-53 - PubMed
  17. Clin Interv Aging. 2014 Aug 16;9:1363-73 - PubMed
  18. Drug Saf. 2010 Feb 1;33(2):101-14 - PubMed
  19. Intern Med. 2008;47(10):885-91 - PubMed
  20. Ann Pharmacother. 2003 Nov;37(11):1694-702 - PubMed
  21. Semin Nephrol. 2009 May;29(3):227-38 - PubMed
  22. Ulster Med J. 2010 May;79(2):104-5 - PubMed
  23. Int J Geriatr Psychiatry. 2000 Mar;15(3):282-3 - PubMed
  24. Am J Kidney Dis. 2013 Jul;62(1):139-49 - PubMed
  25. Multivariate Behav Res. 2011 May;46(3):399-424 - PubMed
  26. J Clin Psychopharmacol. 2003 Aug;23(4):389-99 - PubMed
  27. CNS Drugs. 2009 Dec;23(12):1003-21 - PubMed
  28. Br J Psychiatry. 2010 Jun;196(6):434-9 - PubMed
  29. J Clin Epidemiol. 2008 Apr;61(4):344-9 - PubMed
  30. Ann Intern Med. 2014 Aug 19;161(4):242-8 - PubMed
  31. Hum Psychopharmacol. 2007 Mar;22(2):103-7 - PubMed
  32. Am Heart J. 2002 Aug;144(2):290-6 - PubMed
  33. Am Fam Physician. 2000 Jun 15;61(12):3623-30 - PubMed
  34. Ann Clin Psychiatry. 1997 Sep;9(3):181-3 - PubMed
  35. BMJ Open. 2013 Jan 03;3(1):null - PubMed

Publication Types